• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APR CO., LTD MEDICUBE AGE-R BOOSTER PRO; STIMULATOR, TRANSCUTANEOUS ELECTRICAL, AESTHETIC PURPOSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APR CO., LTD MEDICUBE AGE-R BOOSTER PRO; STIMULATOR, TRANSCUTANEOUS ELECTRICAL, AESTHETIC PURPOSES Back to Search Results
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes Nerve Damage (1979); Undesired Nerve Stimulation (1980); Pain (1994); Sleep Dysfunction (2517); Skin Inflammation/ Irritation (4545)
Date of Event 07/26/2025
Type of Reportable Event Serious Injury
Event or Problem Description
As a concerned consumer and avid user of beauty devices, i am writing to report potential violations of fda regulations by medicube (operated by apr us inc; address: business center, suite 200, irvine, california, 92618, united states of america; email:medicube_uscs@apr-in.Com).The company is unlawfully marketing its products as medical devices without proper fda registration, which misleads consumers and poses health risks.1.Unregistered medical device claims medicube promotes the product named booster pro on its official website (https://medicube.Us/products/age-r-booster-pro) and amazon pages (https://www.Amazon.Com/medicube-booster-beauty-massager- looking/dp/b0cwk6yq7v), advertising medical benefits such as: enhanced absorption, enhanced radiance, elasticity care, facial contouring, pore care, microcurrent.These claims imply the product is intended to treat or modify physiological functions, classifying it as class ii medical devices under fda guidelines.However, a search of the fda device registration database shows no record of medicube products being registered as class ii devices.This violates fd&c act § 510(k), which requires premarket notification for class ii devices before claiming medical uses.2.Personal experience and safety concerns as a consumer, i experienced severe adverse reactions after using this device according to all provided instructions.Within hours of my first use, i developed intense facial nerve pain, persistent skin irritation, and inflammatory breakouts that required medical attention.My experience aligns with many other customers reporting identical severe reactions: permanent acne scarring, nerve damage requiring neurologist consultation, rosacea activation, and systemic effects including sleep disruption and muscle pain.This product is causing medical-grade adverse effects, yet lacks proper fda medical device registration.3.Request for action - enforce 510(k) registration: remove "medicube" from the market until 510(k) clearance and establishment registration are confirmed.- issue warning letters: cite violations of fd&c act, 21 cfr labeling rules, and ftc act.- public warning: alert consumers via fda's medwatch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDICUBE AGE-R BOOSTER PRO
Common Device Name
STIMULATOR, TRANSCUTANEOUS ELECTRICAL, AESTHETIC PURPOSES
Manufacturer (Section D)
APR CO., LTD
300 olympic-ro, songpa-gu
seoul 05551
KS  05551
MDR Report Key22771830
Report NumberMW5174314
Device Sequence Number14587489
Product Code NFO
Combination Product (Y/N)N
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Voluntary
Initial Reporter Occupation Patient
Type of Report Initial
Report Date (Section B) 08/06/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date08/11/2025
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization; Disability;
Patient SexUnknown
-
-